Is survival after transanal total mesorectal excision (taTME) worse than that after traditional total mesorectal excision? A retrospective propensity score-adjusted cohort study
ConclusiontaTME seems to be a good treatment option for patients with rectal cancer and is unlikely to significantly affect local recurrence or survival. However, further investigations concerning the latter are warranted.Trial registrationClinicalTrials.gov (NCT0496910).
Source: International Journal of Colorectal Disease - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Databases & Libraries | Gastroenterology | Laparoscopy | Rectal Cancers | Study